ABSTRACT
Objective:
Delineate an epidemiological profile of patients affected by eyelid tumors, while comparing the rate of correct clinical diagnosis to the gold standard histopathological analysis, verifying the data with the literature.
Methods:
Retrospective analysis of medical records, from 2015 to 2019, of patients submitted to excisional biopsy of the lesions with consequent histopathological classification of the anatomical specimen. Patients’ age and sex and tumors location, clinical diagnosis and histopathological classification were considered.
Results:
In total, 331 eyelid tumors from 273 medical records were inspected. The rate of correct clinical diagnosis, compared to the anatomopathological report, was 88.2%. Of all tumors, 284 (85.8%) were benign. Among malignant tumors, the most prevalent was Basal Cell Carcinoma (80.6%), followed by Squamous Cell Carcinoma (8.5%) and Sebaceous Carcinoma (6.4%); Among benign tumors, it was Papilloma (19.7%), followed by Nevus (13.7%) and Hydrocystoma (13.4%). The mean age was 49.5±20.1 years, with female prevalence (155, 56.4%). Forty-two patients (15.3%) had malignant tumors, 23 (54.8%) were women. The tumors affected 178 lower and 125 upper eyelids, 22 medial canthus and 6 lateral canthus; 169 tumors affected the right side and 162 the left; 19 of the patients had bilateral involvement.
Conclusion:
Histopathological analysis is an essential tool in the diagnosis of eyelid tumors, which, predominantly, are benign affecting more often women with ages close to or over 50 years, on the right side and lower eyelid. These facts must be considered during the ophthalmological consultation due to the probability of malignancy. The best treatment remains surgical excision of the lesion with free margins.
Keywords:
Eyelid neoplasms/diagnosis; Eyelids/pathology; Neoplasms